[
  {
    "title": "大理药业：控股股东及董事拟合计减持不超3.19%股份",
    "href": "http://stock.jrj.com.cn/2022/12/07175137195583.shtml",
    "datetime": "2022-12-07 17:51:00",
    "code": "603963"
  },
  {
    "title": "大理药业(603963.SH)：实控人杨君祥、董事杨君卫拟合计减持不超3.19%股份",
    "href": "http://stock.jrj.com.cn/2022/12/07171137195372.shtml",
    "datetime": "2022-12-07 17:11:19",
    "code": "603963"
  },
  {
    "title": "大理药业：控股股东及其他股东拟减持不超过3.19%股份",
    "href": "http://stock.jrj.com.cn/2022/12/07170937195311.shtml",
    "datetime": "2022-12-07 17:09:53",
    "code": "603963"
  },
  {
    "title": "大理药业(603963.SH)：拟将位于大理市太和街道鹤庆路55号的科技综合楼一层商铺租给建行大理州分行",
    "href": "http://stock.jrj.com.cn/2022/11/17174437147259.shtml",
    "datetime": "2022-11-17 17:44:02",
    "code": "603963"
  },
  {
    "title": "大理药业(603963.SH)：参麦注射液拟中选山东省第三批药品(中成药专项)集采",
    "href": "http://stock.jrj.com.cn/2022/11/09181037124826.shtml",
    "datetime": "2022-11-09 18:10:34",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业8月8日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/08/08180836879721.shtml",
    "datetime": "2022-08-08 18:08:50",
    "code": "603963"
  },
  {
    "title": "大理药业2022年上半年预计亏损750万-950万同比亏损增加 终端订单量下降",
    "href": "http://stock.jrj.com.cn/2022/07/13191136808399.shtml",
    "datetime": "2022-07-13 19:11:13",
    "code": "603963"
  },
  {
    "title": "大理药业(603963.SH)半年度预亏750万元-950万元",
    "href": "http://stock.jrj.com.cn/2022/07/13164936807646.shtml",
    "datetime": "2022-07-13 16:49:20",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业6月16日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/06/16181236735365.shtml",
    "datetime": "2022-06-16 18:12:23",
    "code": "603963"
  },
  {
    "title": "中药股拉升 大理药业等多股涨停 多地出台中医药利好政策",
    "href": "http://stock.jrj.com.cn/2022/06/16103236733616.shtml",
    "datetime": "2022-06-16 10:32:20",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业5月20日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/05/20180936666531.shtml",
    "datetime": "2022-05-20 18:09:43",
    "code": "603963"
  },
  {
    "title": "高位股继续退潮 大理药业等多股开盘跌停",
    "href": "http://stock.jrj.com.cn/2022/05/18093036657487.shtml",
    "datetime": "2022-05-18 09:30:31",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业5月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/05/17181036655904.shtml",
    "datetime": "2022-05-17 18:10:24",
    "code": "603963"
  },
  {
    "title": "大理药业2021年亏损4189.06万同比由盈转亏 董事长杨君祥薪酬108.33万",
    "href": "http://stock.jrj.com.cn/2022/05/04175036557791.shtml",
    "datetime": "2022-05-04 17:50:59",
    "code": "603963"
  },
  {
    "title": "大理药业2022年第一季度亏损320.75万 销售单价、数量有所下滑",
    "href": "http://stock.jrj.com.cn/2022/05/03191136546535.shtml",
    "datetime": "2022-05-03 19:11:50",
    "code": "603963"
  },
  {
    "title": "大理药业(603963.SH)一季度净亏损320.75万元",
    "href": "http://stock.jrj.com.cn/2022/04/27211736486445.shtml",
    "datetime": "2022-04-27 21:17:17",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业4月19日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/19181136400358.shtml",
    "datetime": "2022-04-19 18:11:04",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业4月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/14180536336093.shtml",
    "datetime": "2022-04-14 18:05:53",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业4月13日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/13180636325416.shtml",
    "datetime": "2022-04-13 18:06:51",
    "code": "603963"
  },
  {
    "title": "大理药业(603963.SH)5连板，醒脑静注射液拟备选广东联盟清开灵等中成药集采",
    "href": "http://stock.jrj.com.cn/2022/04/12095136312888.shtml",
    "datetime": "2022-04-12 09:51:15",
    "code": "603963"
  },
  {
    "title": "大理药业(603963.SH)：醒脑静注射液拟备选广东联盟清开灵等中成药集中带量采购",
    "href": "http://stock.jrj.com.cn/2022/04/11190636306528.shtml",
    "datetime": "2022-04-11 19:06:15",
    "code": "603963"
  },
  {
    "title": "大理药业：醒脑静注射液拟备选广东联盟清开灵等中成药集中带量采购",
    "href": "http://stock.jrj.com.cn/2022/04/11190236306503.shtml",
    "datetime": "2022-04-11 19:02:51",
    "code": "603963"
  },
  {
    "title": "大理药业上演“地天板”",
    "href": "http://stock.jrj.com.cn/2022/04/11100136299852.shtml",
    "datetime": "2022-04-11 10:01:43",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业4月7日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/07180536268707.shtml",
    "datetime": "2022-04-07 18:05:08",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业3月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/22181034861535.shtml",
    "datetime": "2022-03-22 18:10:53",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业3月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/14180934824948.shtml",
    "datetime": "2022-03-14 18:09:14",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业3月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/11180634814853.shtml",
    "datetime": "2022-03-11 18:06:52",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业3月9日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/09180734578305.shtml",
    "datetime": "2022-03-09 18:07:34",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业3月3日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/03180634516771.shtml",
    "datetime": "2022-03-03 18:06:36",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业3月2日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/02180634512951.shtml",
    "datetime": "2022-03-02 18:06:02",
    "code": "603963"
  },
  {
    "title": "大理药业2021年预计亏损4000万-4500万 医院终端药品用量下降",
    "href": "http://stock.jrj.com.cn/2022/01/29141134257027.shtml",
    "datetime": "2022-01-29 14:11:05",
    "code": "603963"
  },
  {
    "title": "大理药业(603963.SH)：2021年度预亏4000万元-4500万元",
    "href": "http://stock.jrj.com.cn/2022/01/28215434250047.shtml",
    "datetime": "2022-01-28 21:54:25",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业12月27日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/12/27181034071713.shtml",
    "datetime": "2021-12-27 18:10:11",
    "code": "603963"
  },
  {
    "title": "大理药业(603963.SH)：参麦注射液未中选省际联盟集中带量采购",
    "href": "http://stock.jrj.com.cn/2021/12/23191834053842.shtml",
    "datetime": "2021-12-23 19:18:41",
    "code": "603963"
  },
  {
    "title": "大理药业(603963.SH)：第三季度净亏损478.05万元",
    "href": "http://stock.jrj.com.cn/2021/10/28201533771871.shtml",
    "datetime": "2021-10-28 20:15:16",
    "code": "603963"
  },
  {
    "title": "大理药业：拟使用不超2.4亿元闲置募集资金购买银行理财产品",
    "href": "http://stock.jrj.com.cn/2021/10/12181433680523.shtml",
    "datetime": "2021-10-12 18:14:33",
    "code": "603963"
  },
  {
    "title": "大理药业(603963.SH)上半年净亏损117.30万元 同比转亏",
    "href": "http://stock.jrj.com.cn/2021/08/24160833310154.shtml",
    "datetime": "2021-08-24 16:08:09",
    "code": "603963"
  },
  {
    "title": "大理药业(603963.SH)：已将应缴税款及滞纳金156.78万元全部缴清",
    "href": "http://stock.jrj.com.cn/2021/07/16154933107643.shtml",
    "datetime": "2021-07-16 15:49:18",
    "code": "603963"
  },
  {
    "title": "大理药业：2020年年度权益分派实施 每10股派发现金红利0.46元（含税）",
    "href": "http://stock.jrj.com.cn/2021/06/16161732941064.shtml",
    "datetime": "2021-06-16 16:17:49",
    "code": "603963"
  },
  {
    "title": "大理药业(603963.SH)：2020年度权益分派10派0.46元 股权登记日6月22日",
    "href": "http://stock.jrj.com.cn/2021/06/16155832940771.shtml",
    "datetime": "2021-06-16 15:58:59",
    "code": "603963"
  },
  {
    "title": "【龙虎榜】大理药业5月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/05/18181132777138.shtml",
    "datetime": "2021-05-18 18:11:12",
    "code": "603963"
  },
  {
    "title": "大理药业2020年净利下滑76.07% 董事长杨君祥薪酬89.95万",
    "href": "http://stock.jrj.com.cn/2021/04/21232632419163.shtml",
    "datetime": "2021-04-21 23:26:24",
    "code": "603963"
  },
  {
    "title": "大理药业2021年第一季度净利19万 研发费用减少",
    "href": "http://stock.jrj.com.cn/2021/04/21231632419140.shtml",
    "datetime": "2021-04-21 23:16:42",
    "code": "603963"
  },
  {
    "title": "大理药业(603963.SH)2020年度净利润降76.07%至323.17万元",
    "href": "http://stock.jrj.com.cn/2021/04/21182032417278.shtml",
    "datetime": "2021-04-21 18:20:39",
    "code": "603963"
  },
  {
    "title": "大理药业(603963.SH)：一季度扭亏为盈 净利润18.96万元",
    "href": "http://stock.jrj.com.cn/2021/04/21181832417255.shtml",
    "datetime": "2021-04-21 18:18:34",
    "code": "603963"
  },
  {
    "title": "大理药业2020年预计净利同比减少950万-1050万减少70%-78% 终端药品用量下降",
    "href": "http://stock.jrj.com.cn/2021/01/29215631811861.shtml",
    "datetime": "2021-01-29 21:56:28",
    "code": "603963"
  },
  {
    "title": "大理药业前三季度净利483.52万下滑67.15% 疫情影响销量减少",
    "href": "http://stock.jrj.com.cn/2020/10/31163531181417.shtml",
    "datetime": "2020-10-31 16:35:39",
    "code": "603963"
  },
  {
    "title": "大理药业：召开2020年第二次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/10/14091031048937.shtml",
    "datetime": "2020-10-14 09:10:19",
    "code": "603963"
  },
  {
    "title": "大理药业：第四届董事会第三次会议决议的公告",
    "href": "http://stock.jrj.com.cn/2020/09/30001030862250.shtml",
    "datetime": "2020-09-30 00:10:04",
    "code": "603963"
  },
  {
    "title": "大理药业：将通过建立和完善“一站多中心”科研平台 进行新药/仿制药的开发、产品工艺和质量研究",
    "href": "http://stock.jrj.com.cn/2020/09/18110330775499.shtml",
    "datetime": "2020-09-18 11:03:00",
    "code": "603963"
  },
  {
    "title": "大理药业：首次公开发行限售股上市流通的公告",
    "href": "http://stock.jrj.com.cn/2020/09/17001030765140.shtml",
    "datetime": "2020-09-17 00:10:16",
    "code": "603963"
  },
  {
    "title": "大理药业上市后净利连续降上半年亏损 中信证券保荐",
    "href": "http://stock.jrj.com.cn/2020/08/21070730554635.shtml",
    "datetime": "2020-08-21 07:07:00",
    "code": "603963"
  },
  {
    "title": "大理药业2020年上半年净利54.56万下滑95.54% 销量有所下滑",
    "href": "http://stock.jrj.com.cn/2020/08/18222730532870.shtml",
    "datetime": "2020-08-18 22:27:05",
    "code": "603963"
  },
  {
    "title": "大理药业半年营收降逾三成 整体销售受疫情影响大",
    "href": "http://stock.jrj.com.cn/2020/08/18182830531340.shtml",
    "datetime": "2020-08-18 18:28:41",
    "code": "603963"
  },
  {
    "title": "大理药业：2019年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/05/15013029674881.shtml",
    "datetime": "2020-05-15 01:30:01",
    "code": "603963"
  },
  {
    "title": "大理药业第一季度亏损112.96万 较上年同期由盈转亏",
    "href": "http://stock.jrj.com.cn/2020/04/23195029360237.shtml",
    "datetime": "2020-04-23 19:50:03",
    "code": "603963"
  },
  {
    "title": "大理药业披露送转预案：拟10送转3股",
    "href": "http://stock.jrj.com.cn/hotstock/2020/04/22224729351996.shtml",
    "datetime": "2020-04-22 22:47:00",
    "code": "603963"
  },
  {
    "title": "大理药业：2019年净利1350.55万元 拟10转3股",
    "href": "http://stock.jrj.com.cn/2020/04/22211729351444.shtml",
    "datetime": "2020-04-22 21:17:03",
    "code": "603963"
  },
  {
    "title": "大理药业：2019年净利同比增26% 拟10转3",
    "href": "http://stock.jrj.com.cn/2020/04/22193829350889.shtml",
    "datetime": "2020-04-22 19:38:00",
    "code": "603963"
  },
  {
    "title": "大理药业：捐赠价值不超过600万元药品支持疫情防控",
    "href": "http://stock.jrj.com.cn/2020/02/23165628876782.shtml",
    "datetime": "2020-02-23 16:56:00",
    "code": "603963"
  },
  {
    "title": "大理药业：2019年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/11/15002028401600.shtml",
    "datetime": "2019-11-15 00:20:01",
    "code": "603963"
  },
  {
    "title": "大理药业自2019年7月12日至本公告披露之日累计收到与收益相关的政府补助270万元",
    "href": "http://stock.jrj.com.cn/2019/11/03135328343709.shtml",
    "datetime": "2019-11-03 13:53:34",
    "code": "603963"
  },
  {
    "title": "大理药业收到政府补助270.1万元",
    "href": "http://stock.jrj.com.cn/2019/11/01155628339200.shtml",
    "datetime": "2019-11-01 15:56:18",
    "code": "603963"
  },
  {
    "title": "大理药业：关于召开2019年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/10/30011028321047.shtml",
    "datetime": "2019-10-30 01:10:04",
    "code": "603963"
  },
  {
    "title": "大理药业：关于第三届董事会第十四次会议决议的公告",
    "href": "http://stock.jrj.com.cn/2019/10/23011028285067.shtml",
    "datetime": "2019-10-23 01:10:03",
    "code": "603963"
  },
  {
    "title": "大理药业：2019年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/10/23011028285038.shtml",
    "datetime": "2019-10-23 01:10:02",
    "code": "603963"
  },
  {
    "title": "大理药业前三季度净利1472万 同比增长172.27%",
    "href": "http://stock.jrj.com.cn/2019/10/22194728284274.shtml",
    "datetime": "2019-10-22 19:47:08",
    "code": "603963"
  },
  {
    "title": "大理药业：2019年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/09112027952904.shtml",
    "datetime": "2019-08-09 11:20:07",
    "code": "603963"
  },
  {
    "title": "大理药业：关于第三届董事会第十三次会议决议的公告",
    "href": "http://stock.jrj.com.cn/2019/08/09112027952905.shtml",
    "datetime": "2019-08-09 11:20:07",
    "code": "603963"
  },
  {
    "title": "大理药业：上半年净利1223万元 同比增近13倍",
    "href": "http://stock.jrj.com.cn/2019/08/08163827947914.shtml",
    "datetime": "2019-08-08 16:38:53",
    "code": "603963"
  },
  {
    "title": "大理药业：上半年净利1223万元 同比增逾12倍",
    "href": "http://stock.jrj.com.cn/2019/08/08162827947887.shtml",
    "datetime": "2019-08-08 16:28:00",
    "code": "603963"
  },
  {
    "title": "大理药业：上半年净利1223.38万元 同比增长1281.05％",
    "href": "http://stock.jrj.com.cn/2019/08/08162527947852.shtml",
    "datetime": "2019-08-08 16:25:46",
    "code": "603963"
  },
  {
    "title": "大理药业2019年上半年净利1223万 产品到效期报废损失大幅减少",
    "href": "http://stock.jrj.com.cn/2019/08/08161827947820.shtml",
    "datetime": "2019-08-08 16:18:55",
    "code": "603963"
  },
  {
    "title": "大理药业：2018年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2019/06/02194027654166.shtml",
    "datetime": "2019-06-02 19:40:03",
    "code": "603963"
  },
  {
    "title": "大理药业：2018年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/05/10004027550051.shtml",
    "datetime": "2019-05-10 00:40:09",
    "code": "603963"
  },
  {
    "title": "大理药业一季度净利740万同比下滑15% 现金流量净额-67万",
    "href": "http://stock.jrj.com.cn/2019/04/28185027502460.shtml",
    "datetime": "2019-04-28 18:50:34",
    "code": "603963"
  },
  {
    "title": "大理药业：2019年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/26053027485846.shtml",
    "datetime": "2019-04-26 05:30:14",
    "code": "603963"
  },
  {
    "title": "大理药业：关于第三届董事会第十二次会议决议的公告",
    "href": "http://stock.jrj.com.cn/2019/04/26053027485845.shtml",
    "datetime": "2019-04-26 05:30:14",
    "code": "603963"
  },
  {
    "title": "大理药业广告费2.55亿 两年增53倍吞噬净利",
    "href": "http://stock.jrj.com.cn/2019/04/19080027426654.shtml",
    "datetime": "2019-04-19 08:00:01",
    "code": "603963"
  },
  {
    "title": "大理药业：2018年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/16011027401098.shtml",
    "datetime": "2019-04-16 01:10:04",
    "code": "603963"
  },
  {
    "title": "大理药业：关于召开2018年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/04/16011027401097.shtml",
    "datetime": "2019-04-16 01:10:04",
    "code": "603963"
  },
  {
    "title": "大理药业：关于第三届董事会第十一次会议决议的公告",
    "href": "http://stock.jrj.com.cn/2019/04/16011027401096.shtml",
    "datetime": "2019-04-16 01:10:04",
    "code": "603963"
  },
  {
    "title": "大理药业去年净利1070万元 同比下滑76% 董事长杨君祥年薪为72万元",
    "href": "http://stock.jrj.com.cn/2019/04/15232527400360.shtml",
    "datetime": "2019-04-15 23:25:18",
    "code": "603963"
  },
  {
    "title": "大理药业：2018年净利润1070.05万元 拟10转3派0.77元",
    "href": "http://stock.jrj.com.cn/2019/04/15174427397930.shtml",
    "datetime": "2019-04-15 17:44:26",
    "code": "603963"
  },
  {
    "title": "大理药业常务副总经理李现国辞职 公司财务总监李绍云暂代",
    "href": "http://stock.jrj.com.cn/2019/04/03075427311901.shtml",
    "datetime": "2019-04-03 07:54:39",
    "code": "603963"
  },
  {
    "title": "大理药业发布澄清公告 公司并无工业大麻业务",
    "href": "http://stock.jrj.com.cn/2019/03/06134127126237.shtml",
    "datetime": "2019-03-06 13:41:40",
    "code": "603963"
  },
  {
    "title": "大理药业：公司没有工业大麻相关业务",
    "href": "http://stock.jrj.com.cn/2019/03/05190027121787.shtml",
    "datetime": "2019-03-05 19:00:17",
    "code": "603963"
  },
  {
    "title": "大理药业澄清：没有工业大麻相关业务 没有开展该项业务计划",
    "href": "http://stock.jrj.com.cn/2019/03/05185327121758.shtml",
    "datetime": "2019-03-05 18:53:01",
    "code": "603963"
  },
  {
    "title": "大理药业业绩变脸 净利将减少逾7成",
    "href": "http://stock.jrj.com.cn/2019/01/29211326998493.shtml",
    "datetime": "2019-01-29 21:13:23",
    "code": "603963"
  },
  {
    "title": "大理药业2018年净利预计减少3245万元到3445万元",
    "href": "http://stock.jrj.com.cn/2019/01/29114926996343.shtml",
    "datetime": "2019-01-29 11:49:15",
    "code": "603963"
  },
  {
    "title": "大理药业：2018年年度业绩预减公告",
    "href": "http://stock.jrj.com.cn/2019/01/29011026994008.shtml",
    "datetime": "2019-01-29 01:10:02",
    "code": "603963"
  },
  {
    "title": "大理药业：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/28231026993773.shtml",
    "datetime": "2019-01-28 23:10:00",
    "code": "603963"
  },
  {
    "title": "大理药业：2018年净利预降73%到78%",
    "href": "http://stock.jrj.com.cn/2019/01/28164526992315.shtml",
    "datetime": "2019-01-28 16:45:00",
    "code": "603963"
  },
  {
    "title": "大理药业：2018年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/11/29214025422681.shtml",
    "datetime": "2018-11-29 21:40:57",
    "code": "603963"
  },
  {
    "title": "大理药业：关于召开2018年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/11/13231025341134.shtml",
    "datetime": "2018-11-13 23:10:04",
    "code": "603963"
  },
  {
    "title": "大理药业销售费占营收7成拖累业绩 IPO募投项目终止",
    "href": "http://stock.jrj.com.cn/2018/10/31081725283696.shtml",
    "datetime": "2018-10-31 08:17:44",
    "code": "603963"
  },
  {
    "title": "大理药业：2018年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/10/30080025277627.shtml",
    "datetime": "2018-10-30 08:00:35",
    "code": "603963"
  },
  {
    "title": "大理药业：关于第三届董事会第十次会议决议的公告",
    "href": "http://stock.jrj.com.cn/2018/10/30080025277628.shtml",
    "datetime": "2018-10-30 08:00:35",
    "code": "603963"
  },
  {
    "title": "大理药业：首次公开发行限售股上市流通的公告",
    "href": "http://stock.jrj.com.cn/2018/09/18231025109813.shtml",
    "datetime": "2018-09-18 23:10:02",
    "code": "603963"
  },
  {
    "title": "大理药业：关于第三届董事会第九次会议决议的公告",
    "href": "http://stock.jrj.com.cn/2018/08/14214024951596.shtml",
    "datetime": "2018-08-14 21:40:00",
    "code": "603963"
  },
  {
    "title": "大理药业：2018年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/08/14212024951542.shtml",
    "datetime": "2018-08-14 21:20:10",
    "code": "603963"
  },
  {
    "title": "中药智造十年行动计划启动 机构看好10只龙头股机会",
    "href": "http://stock.jrj.com.cn/2018/07/11010424797012.shtml",
    "datetime": "2018-07-11 01:04:00",
    "code": "603963"
  },
  {
    "title": "大理药业：2017年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2018/06/27223024736484.shtml",
    "datetime": "2018-06-27 22:30:11",
    "code": "603963"
  },
  {
    "title": "大理药业年报推10转3派1元 股权登记7月4日",
    "href": "http://stock.jrj.com.cn/2018/06/27165124735186.shtml",
    "datetime": "2018-06-27 16:51:28",
    "code": "603963"
  },
  {
    "title": "涨停复盘:上证下探2900触底反弹望固底 强势股成主攻",
    "href": "http://stock.jrj.com.cn/2018/06/20171924705478.shtml",
    "datetime": "2018-06-20 17:19:47",
    "code": "603963"
  },
  {
    "title": "大理药业：2017年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/05/23235024581709.shtml",
    "datetime": "2018-05-23 23:50:11",
    "code": "603963"
  },
  {
    "title": "大理药业：关于召开2017年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/04/27100024463423.shtml",
    "datetime": "2018-04-27 10:00:36",
    "code": "603963"
  },
  {
    "title": "大理药业：2017年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/04/27100024463421.shtml",
    "datetime": "2018-04-27 10:00:35",
    "code": "603963"
  },
  {
    "title": "大理药业：2018年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/04/27100024463422.shtml",
    "datetime": "2018-04-27 10:00:35",
    "code": "603963"
  },
  {
    "title": "大理药业：关于第三届董事会第八次会议决议的公告",
    "href": "http://stock.jrj.com.cn/2018/04/27100024463420.shtml",
    "datetime": "2018-04-27 10:00:35",
    "code": "603963"
  },
  {
    "title": "医药股掀涨停潮 诚意药业、大理药业等8股涨停",
    "href": "http://stock.jrj.com.cn/2018/04/10144524368208.shtml",
    "datetime": "2018-04-10 14:45:00",
    "code": "603963"
  },
  {
    "title": "大理药业：关于第三届董事会第七次会议决议的公告",
    "href": "http://stock.jrj.com.cn/2018/03/15222024248307.shtml",
    "datetime": "2018-03-15 22:20:01",
    "code": "603963"
  },
  {
    "title": "大博医疗、大理药业、哈三联9月22日上市定位分析",
    "href": "http://stock.jrj.com.cn/ipo/2017/09/21143923149475.shtml",
    "datetime": "2017-09-21 14:39:33",
    "code": "603963"
  },
  {
    "title": "哈三联与大理药业网上申购中签结果出炉",
    "href": "http://stock.jrj.com.cn/ipo/2017/09/13213923109615.shtml",
    "datetime": "2017-09-13 21:39:00",
    "code": "603963"
  },
  {
    "title": "大理药业网上申购中签号出炉共22500个 14日缴款",
    "href": "http://stock.jrj.com.cn/ipo/2017/09/13203723109408.shtml",
    "datetime": "2017-09-13 20:37:19",
    "code": "603963"
  },
  {
    "title": "大理药业网上发行最终中签率为0.0243%",
    "href": "http://stock.jrj.com.cn/ipo/2017/09/13084523104992.shtml",
    "datetime": "2017-09-13 08:45:26",
    "code": "603963"
  },
  {
    "title": "大理药业IPO：产能利用率仅3成 却还要募资扩大产能",
    "href": "http://stock.jrj.com.cn/ipo/2017/07/18072922761614.shtml",
    "datetime": "2017-07-18 07:29:05",
    "code": "603963"
  }
]